|
|
|
|
LEADER |
02693nam a2200361 u 4500 |
001 |
EB000943500 |
003 |
EBX01000000000000000737090 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
150223 r ||| eng |
020 |
|
|
|a 0309256941
|
020 |
|
|
|a 9780309256940
|
100 |
1 |
|
|a Fain, Barbara
|
245 |
0 |
0 |
|a Public engagement on facilitating access to antiviral medications and information in an influenza pandemic
|h Elektronische Ressource
|b workshop series summary
|c Barbara Fain, Kristin Viswanathan, and Bruce M. Altevogt, rapporteurs
|
260 |
|
|
|a Washington, D.C.
|b National Academies Press
|c 2012, c2012
|
300 |
|
|
|a 1 PDF file (xiv, 42p.)
|b ill
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Health Services Accessibility
|
653 |
|
|
|a United States
|
653 |
|
|
|a Antiviral Agents
|
653 |
|
|
|a Influenza, Human / epidemiology
|
653 |
|
|
|a Influenza, Human / therapy
|
653 |
|
|
|a Public Opinion
|
653 |
|
|
|a Disaster Planning
|
700 |
1 |
|
|a Viswanathan, Kristin
|
700 |
1 |
|
|a Altevogt, Bruce M.
|
710 |
2 |
|
|a Institute of Medicine (U.S.)
|b Forum on Medical and Public Health Preparedness for Catastrophic Events
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK95229
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 140
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a In response to a request from the Centers for Disease Control and Prevention (CDC), the Institute of Medicine's (IOM's) Forum on Medical and Public Health Preparedness for Catastrophic Events (Preparedness Forum) designed and convened a series of workshops ("community conversations") that explored the public's perception of potential alternative strategies for facilitating access to antiviral medications and treatment advice during an influenza pandemic. Based on its statement of task (Box 1) the workshop planning committee convened members of the general public in three locations--Fort Benton, Montana (MT), Chattanooga, Tennessee (TN), and Los Angeles, California (CA)--during February and March 2012 to consider the acceptability of several alternative strategies of delivering antiviral medication to the public during a pandemic. These discussions will help to inform potential strategies still in the development stages at the CDC. The public was asked to consider, if an influenza pandemic were to strike, how the normal systems for prescribing and dispensing antiviral medications could be adjusted to ensure that the public has quick, safe, and equitable access to these potentially lifesaving drugs and to information about the pandemic and treatment options
|